中国低资源地区女性乳腺癌筛查困境及对策

闫慧姣; 王苏蒙; 任文辉; 贾萌萌; 乔友林

doi:10.11847/zgggws1141859

中国低资源地区女性乳腺癌筛查困境及对策

doi: 10.11847/zgggws1141859

1.
中国医学科学院北京协和医学院群医学及公共卫生学院全球健康学系，北京 100730
2.
国家癌症中心国家肿瘤临床医学研究中心中国医学科学院北京协和医学院肿瘤医院，北京 100021

基金项目: 中国医学科学院医学与健康科技创新工程服务“一带一路”战略先导专项（2017 – I2M – B&R – 03）；世界卫生组织/国际癌症研究署合作项目（CRA/SCR/2019/1）

详细信息

作者简介:
闫慧姣（1995 – ），博士在读，研究方向：肿瘤流行病学

通信作者:
乔友林， E-mail：qiaoy@cicams.ac.cn

计量
- 文章访问数: 46
- HTML全文浏览量: 14
- PDF下载量: 13
- 被引次数: 0
出版历程
- 接收日期: 2023-03-28
- 录用日期: 2023-09-07
- 修回日期: 2023-06-26
- 网络出版日期: 2023-11-08
- 刊出日期: 2023-10-01

Difficulties in and strategies on breast cancer screening in low-resource regions of China: a brief comment

1.
School of Population Medicine and Public Health, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China
2.
National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China

More Information

Corresponding author: QIAO Youlin, E-mail：qiaoy@cicams.ac.cn

摘要

摘要: 中国低卫生资源地区乳腺癌疾病负担增长速度较快，防控形势严峻。中国普遍采用超声作为初筛方法，但超声对操作者依赖性较强，应用于乳腺癌筛查中的长期效果尚需高质量前瞻性队列研究进行评估。自动乳腺容积超声和人工智能技术的发展将有望促进低卫生资源地区乳腺癌筛查质量的提升，但其在乳腺癌筛查中的效果有待进一步验证，应用模式也需继续探索。鉴于我国不同地区经济和医疗卫生条件差异较大，因此需要探索适配不同地区的筛查策略，尤其应重点关注低卫生资源地区的需求。
- 乳腺癌 /
- 筛查 /
- 低资源地区
Abstract: The burden of breast cancer is increasing fast in low resource areas of China. Uultrasonography is widely used as a primary method for breast cancer screening in China. However, effective ultrasonography is highly dependent on the operators’ professional skills and long-term efficacy of the ultrasonography screening needs to be evaluated with high-quality prospective cohort studies. The development of automated breast volume scanner and artificial intelligence technology is expected to promote the performance of breast cancer screening in regions with low health resources; the efficacy of the two means in breast cancer screening needs to be further verified and the implementation of the new process needs to be explored. Given the economic and medical heterogeneity across different regions of China, it is necessary to explore screening strategies suitable for different situations, especially for regions with low health resources.
- breast cancer /
- screening /
- low-resource region

HTML全文

参考文献(28)

[1]	World Health Organization. The Global Breast Cancer Initiative (GBCI)[EB/OL]. (2022 – 06 – 30)[2023 – 05 – 08]. https://www.who.int/publications/m/item/the-global-breast-cancer-initiative-gbci.
[2]	Zhang M, Zhong YJ, Bao HL, et al. Breast cancer screening rates among women aged 20 years and above – China, 2015[J]. China CDC Weekly, 2021, 3(13): 267 – 273. doi: 10.46234/ccdcw2021.078
[3]	Denny L, De Sanjose S, Mutebi M, et al. Interventions to close the divide for women with breast and cervical cancer between low-income and middle-income countries and high-income countries[J]. The Lancet, 2017, 389(10071): 861 – 870. doi: 10.1016/S0140-6736(16)31795-0
[4]	Samarasekera U, Horton R. Women's cancers: shining a light on a neglected health inequity[J]. The Lancet, 2017, 389(10071): 771 – 773. doi: 10.1016/S0140-6736(16)31798-6
[5]	Zhang SW, Sun KX, Zheng RS, et al. Cancer incidence and mortality in China, 2015[J]. Journal of the National Cancer Center, 2021, 1(1): 2 – 11. doi: 10.1016/j.jncc.2020.12.001
[6]	张敏璐, 彭鹏, 吴春晓, 等. 2008 — 2012年中国肿瘤登记地区女性乳腺癌发病和死亡分析[J]. 中华肿瘤杂志, 2019, 41(4): 315 – 320.
[7]	李贺, 郑荣寿, 张思维, 等. 2014年中国女性乳腺癌发病与死亡分析[J]. 中华肿瘤杂志, 2018, 40(3): 166 – 171.
[8]	Zeng HM, Chen WQ, Zheng RS, et al. Changing cancer survival in China during 2003 – 15: a pooled analysis of 17 population-based cancer registries[J]. The Lancet Global Health, 2018, 6(5): e555 – e567. doi: 10.1016/S2214-109X(18)30127-X
[9]	SEER*Explorer. Surveillance research program, National Cancer Institute[EB/OL]. (2023 – 04 – 19)[2023 – 05 – 08]. https://seer.cancer.gov/explorer.
[10]	Fitzgerald S P. Breast-cancer screening – viewpoint of the IARC working group[J]. The New England Journal of Medicine, 2015, 373(15): 1479.
[11]	Carney PA, Miglioretti DL, Yankaskas BC, et al. Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography[J]. Annals of Internal Medicine, 2003, 138(3): 168 – 175. doi: 10.7326/0003-4819-138-3-200302040-00008
[12]	Sprague BL, Ahern TP, Herschorn SD, et al. Identifying key barriers to effective breast cancer control in rural settings[J]. Preventive Medicine, 2021, 152(Pt 2): 106741.
[13]	Monticciolo DL, Newell MS, Moy L, et al. Breast cancer screening in women at higher-than-average risk: recommendations from the ACR[J]. Journal of the American College of Radiology, 2018, 15(3): 408 – 414. doi: 10.1016/j.jacr.2017.11.034
[14]	Berg WA, Blume JD, Cormack JB, et al. Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer[J]. JAMA, 2008, 299(18): 2151 – 2163. doi: 10.1001/jama.299.18.2151
[15]	Siu AL. Screening for breast cancer: U. S. preventive services task force recommendation statement[J]. Annals of Internal Medicine, 2016, 164(4): 279 – 296. doi: 10.7326/M15-2886
[16]	Berg WA, Zhang Z, Lehrer D, et al. Detection of breast cancer with addition of annual screening ultrasound or a single screening MRI to mammography in women with elevated breast cancer risk[J]. JAMA, 2012, 307(13): 1394 – 1404. doi: 10.1001/jama.2012.388
[17]	Ohuchi N, Suzuki A, Sobue T, et al. Sensitivity and specificity of mammography and adjunctive ultrasonography to screen for breast cancer in the Japan Strategic Anti-cancer Randomized Trial (J-START): a randomised controlled trial[J]. The Lancet, 2016, 387(10016): 341 – 348. doi: 10.1016/S0140-6736(15)00774-6
[18]	Hooley RJ, Greenberg KL, Stackhouse RM, et al. Screening US in patients with mammographically dense breasts: initial experience with Connecticut Public Act 09-41[J]. Radiology, 2012, 265(1): 59 – 69. doi: 10.1148/radiol.12120621
[19]	Parris T, Wakefield D, Frimmer H. Real world performance of screening breast ultrasound following enactment of Connecticut Bill 458[J]. The Breast Journal, 2013, 19(1): 64 – 70. doi: 10.1111/tbj.12053
[20]	Berg WA, Bandos AI, Mendelson EB, et al. Ultrasound as the primary screening test for breast cancer: analysis from ACRIN 6666[J]. Journal of the National Cancer Institute, 2016, 108(4): djv367. doi: 10.1093/jnci/djv367
[21]	Yang L, Wang SF, Zhang LW, et al. Performance of ultrasonography screening for breast cancer: a systematic review and meta-analysis[J]. BMC Cancer, 2020, 20(1): 499. doi: 10.1186/s12885-020-06992-1
[22]	Yuan WH, Hsu HC, Chen YY, et al. Supplemental breast cancer-screening ultrasonography in women with dense breasts: a systematic review and meta-analysis[J]. British Journal of Cancer, 2020, 123(4): 673 – 688. doi: 10.1038/s41416-020-0928-1
[23]	Lin X, Jia MM, Zhou X, et al. The diagnostic performance of automated versus handheld breast ultrasound and mammography in symptomatic outpatient women: a multicenter, cross-sectional study in China[J]. European Radiology, 2021, 31(2): 947 – 957. doi: 10.1007/s00330-020-07197-7
[24]	McKinney SM, Sieniek M, Godbole V, et al. International evaluation of an AI system for breast cancer screening[J]. Nature, 2020, 577(7788): 89 – 94. doi: 10.1038/s41586-019-1799-6
[25]	Rodriguez-Ruiz A, Lång K, Gubern-Merida A, et al. Stand-alone artificial intelligence for breast cancer detection in mammography: comparison with 101 radiologists[J]. Journal of the National Cancer Institute, 2019, 111(9): 916 – 922. doi: 10.1093/jnci/djy222
[26]	Freeman K, Geppert J, Stinton C, et al. Use of artificial intelligence for image analysis in breast cancer screening programmes: systematic review of test accuracy[J]. BMJ, 2021, 374: n1872.
[27]	Qin VM, McPake B, Raban MZ, et al. Rural and urban differences in health system performance among older Chinese adults: cross-sectional analysis of a national sample[J]. BMC Health Services Research, 2020, 20(1): 372. doi: 10.1186/s12913-020-05194-6
[28]	Mandal R, Basu P. Cancer screening and early diagnosis in low and middle income countries: current situation and future perspectives[J]. Bundesgesundheitsblatt-Gesundheitsforschung-Gesundheitsschutz, 2018, 61(12): 1505 – 1512. doi: 10.1007/s00103-018-2833-9